Karyopharm Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).
CEORichard A. Paulson
CEORichard A. Paulson
Employees442
Employees442
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded2008
Founded2008
Employees442
Employees442
KPTI Key Statistics
Market cap386.06M
Market cap386.06M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.93M
Average volume1.93M
High today$3.54
High today$3.54
Low today$3.27
Low today$3.27
Open price$3.38
Open price$3.38
Volume2.02M
Volume2.02M
52 Week high$14.73
52 Week high$14.73
52 Week low$2.45
52 Week low$2.45
Analyst ratings
60%
of 10 ratingsBuy
60%
Hold
40%
Sell
0%
KPTI Earnings
-$0.74
-$0.34
$0.06
$0.46
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated-$0.34 per share
Estimated-$0.34 per share
ActualExpected Feb 17, Pre-Market
ActualExpected Feb 17, Pre-Market